CY1120283T1 - Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης - Google Patents

Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης

Info

Publication number
CY1120283T1
CY1120283T1 CY20181100570T CY181100570T CY1120283T1 CY 1120283 T1 CY1120283 T1 CY 1120283T1 CY 20181100570 T CY20181100570 T CY 20181100570T CY 181100570 T CY181100570 T CY 181100570T CY 1120283 T1 CY1120283 T1 CY 1120283T1
Authority
CY
Cyprus
Prior art keywords
therapeutic system
interderative
rivastigmin
producers
administration
Prior art date
Application number
CY20181100570T
Other languages
English (en)
Inventor
Heike Prinz
Björn Schurad
Thomas Beckert
Kristina Linder
Original Assignee
Luye Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43383419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1120283(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Luye Pharma Ag filed Critical Luye Pharma Ag
Publication of CY1120283T1 publication Critical patent/CY1120283T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
    • A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Manufacturing & Machinery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Η παρούσα εφεύρεση αφορά ένα διαδερμικό θεραπευτικό σύστημα για χορήγηση μιας δραστικής ουσίας μέσω του δέρματος, το οποίο περιλαμβάνει a) μια στοιβάδα επικάλυψης b) μια ευρισκόμενη επάνω στην στοιβάδα επικάλυψης δεξαμενή, η οποία περιλαμβάνει μια πολυμερική μήτρα που περιέχει την δραστική ουσία, c) μια ευρισκόμενη επάνω στην δεξαμενή συγκολλητική στοιβάδα, η οποία περιλαμβάνει μια κόλλα επαφής και d) μια ευρισκόμενη επάνω στην συγκολλητική στοιβάδα αφαιρούμενη στοιβάδα, όπου η δραστική ουσία είναι η ριβαστιγμίνη, το φυσιολογικά αποδεκτό άλας, η ένυδρη μορφή, η επιδιαλυτωμένη μορφή ή το παράγωγο αυτής, χαρακτηριζόμενο από το ότι η πολυμερική μήτρα της δεξαμενής δεν έχει ούτε υδροξυλομάδες ούτε καρβοξυλομάδες.
CY20181100570T 2009-12-22 2018-05-25 Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης CY1120283T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09180413 2009-12-22
EP10154648 2010-02-25
PCT/EP2010/069654 WO2011076621A2 (de) 2009-12-22 2010-12-14 Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
EP10790565.5A EP2515886B1 (de) 2009-12-22 2010-12-14 Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten

Publications (1)

Publication Number Publication Date
CY1120283T1 true CY1120283T1 (el) 2019-07-10

Family

ID=43383419

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100570T CY1120283T1 (el) 2009-12-22 2018-05-25 Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης

Country Status (16)

Country Link
US (1) US8962014B2 (el)
EP (1) EP2515886B1 (el)
JP (1) JP6083734B2 (el)
KR (1) KR101674240B1 (el)
CN (1) CN102711744B (el)
AU (1) AU2010335309B2 (el)
BR (1) BR112012017168B1 (el)
CA (1) CA2785117C (el)
CY (1) CY1120283T1 (el)
DK (1) DK2515886T3 (el)
ES (1) ES2670227T3 (el)
MX (1) MX350357B (el)
NO (1) NO2515886T3 (el)
PL (1) PL2515886T3 (el)
PT (1) PT2515886T (el)
WO (1) WO2011076621A2 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150626A (en) 2009-10-30 2014-02-07 Ix Biopharma Ltd Fast dissolving solid dosage form
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
ES2545094T3 (es) * 2010-12-14 2015-09-08 Acino Ag Sistema terapéutico transdérmico para la administración de un principio activo
BR112013029945A2 (pt) * 2011-05-20 2017-01-31 Sk Chemicals Co Ltd emplastro contendo rivastigmina
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
JP6102739B2 (ja) * 2011-08-31 2017-03-29 東洋インキＳｃホールディングス株式会社 貼付剤
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
JP5093545B1 (ja) * 2012-02-28 2012-12-12 ニチバン株式会社 貼付剤
US20140083878A1 (en) * 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device
CN103933018A (zh) * 2013-01-18 2014-07-23 江苏康倍得药业有限公司 一种透皮给药系统
US10308408B2 (en) 2014-05-15 2019-06-04 Nichiban Co., Ltd. Packaging for adhesive patch containing rivastigmine
CN106715629B (zh) * 2014-09-23 2019-07-12 伊奎斯塔化学有限公司 聚烯烃基组合物、粘合剂，以及由其制备的相关多层结构
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
EP3267875A4 (en) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Craving input and support system
DE102015119789A1 (de) * 2015-11-16 2017-05-18 Denso-Holding Gmbh & Co. Korrosionsschutzzusammensetzung umfassend Polyisobutylene
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3600262A4 (en) 2017-03-24 2020-09-16 E Ink California, LLC MICROCELL DELIVERY SYSTEMS INCLUDING CHARGED OR MAGNETIC PARTICLES TO REGULATE THE RATE OF ACTIVE INGREDIENT DELIVERY
JP2020510086A (ja) 2017-03-24 2020-04-02 イー インク カリフォルニア， エルエルシー 活性分子を送達するためのマイクロセルシステム
WO2019099320A1 (en) 2017-11-14 2019-05-23 E Ink California, Llc Electrophoretic active delivery system including porous conductive electrode layer
BR112020021173A2 (pt) * 2018-04-17 2021-01-19 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico para a administração transdérmica de solifenacina
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems
CN114728155B (zh) 2019-11-27 2024-04-26 伊英克公司 包括具有电蚀密封层的微单元的有益剂输送系统
CN116322881A (zh) 2020-10-29 2023-06-23 伊英克加利福尼亚有限责任公司 用于递送有益剂的微单元系统
CN116507322A (zh) 2020-10-29 2023-07-28 伊英克加利福尼亚有限责任公司 用于递送亲水活性分子的微单元系统

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
JPS63307818A (ja) 1987-06-08 1988-12-15 Sekisui Chem Co Ltd 経皮吸収貼付剤
JPH07116025B2 (ja) 1988-03-11 1995-12-13 積水化学工業株式会社 貼付剤
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
JPH08193030A (ja) 1995-01-12 1996-07-30 Nitto Denko Corp エメダスチン貼付製剤
JPH10152434A (ja) 1996-09-26 1998-06-09 Nitto Denko Corp 経皮吸収型製剤
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19814087A1 (de) * 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
JP4394443B2 (ja) * 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
JP4478757B2 (ja) 2002-04-19 2010-06-09 日東電工株式会社 ビソプロロール含有貼付剤
NZ555693A (en) * 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CN1994290B (zh) * 2006-01-04 2011-03-16 上海医药工业研究院 卡巴拉汀透皮贴剂及其制备方法
RU2428179C2 (ru) * 2006-05-08 2011-09-10 Тейкоку Сейяку Ко., Лтд. Препаративные формы лекарственных средств против слабоумия для чрескожного введения
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
JP2009022730A (ja) * 2007-06-18 2009-02-05 Kyoritsu Yakuhin Kogyo Kk 貼付剤

Also Published As

Publication number Publication date
AU2010335309A1 (en) 2012-07-19
CN102711744B (zh) 2014-06-25
BR112012017168A2 (pt) 2018-05-02
CA2785117A1 (en) 2011-06-30
WO2011076621A2 (de) 2011-06-30
EP2515886A2 (de) 2012-10-31
JP2013515025A (ja) 2013-05-02
MX2012007214A (es) 2012-09-12
PL2515886T3 (pl) 2018-08-31
EP2515886B1 (de) 2018-04-11
ES2670227T3 (es) 2018-05-29
MX350357B (es) 2017-09-05
US20130261571A1 (en) 2013-10-03
BR112012017168B1 (pt) 2022-03-15
PT2515886T (pt) 2018-05-23
KR20120128606A (ko) 2012-11-27
NO2515886T3 (el) 2018-09-08
AU2010335309B2 (en) 2015-08-20
CN102711744A (zh) 2012-10-03
WO2011076621A3 (de) 2012-02-09
CA2785117C (en) 2016-12-06
KR101674240B1 (ko) 2016-11-08
JP6083734B2 (ja) 2017-02-22
DK2515886T3 (en) 2018-06-14
US8962014B2 (en) 2015-02-24

Similar Documents

Publication Publication Date Title
CY1120283T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης
CY1123712T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
CY1117770T1 (el) Διαδερμικο θεραπευτικο συστημα για χορηγηση της δραστικης ουσιας βουπρενορφινη
CY1122575T1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
CY1119582T1 (el) Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
HK1143301A1 (en) Apparatus for the formation of multiple microconduits
CL2012000949A1 (es) Compuestos derivados de 3-[(4-fenilpiperidin-1-il)carbonill]piperidina inhibidores de la proteina hdm2; composicion farmaceutica que comprende unoi de los compustos; y su uso de los compuestos en la preparacion de un medicamento util para el tratamiento d distintos tipos de cancer, tales como vejiga, de colon de riñon y otros.
CR20150360A (es) Sistema de liberación transdérmica
BR112017025108A2 (pt) compostos seletivos de pyy e usos dos mesmos
SG184244A1 (en) Medical devices including medicaments and methods of making and using same
BR112012026801B8 (pt) conjugados de pirrolobenzodiazepina direcionados, composição farmacêutica, uso dos mesmos para tratamento de uma doença proliferativa ou autoimune e ligante de medicamento
EA201190300A1 (ru) Микроэлектрод и множественные микроэлектроды, содержащие устройства для высвобождения лекарственных средств в ткани
CL2012000702A1 (es) Uso de un agonista del receptor de acetilcolina nicotinico alfa-7 para el tratamiento de la discinesia asociada a la terapia con agonista de dopamina en la enfermedad de parkinson.
WO2009120484A3 (en) Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
BRPI0809511B8 (pt) dispositivo de distribuição transdérmica de microagulha
MX2012002727A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
CO6410278A2 (es) Disoluciones pediátricas que continen un beta-bloqueante
CL2009000727A1 (es) Compuestos derivados de n-hidroxi-3-fenilprop-2-enemida y n-hidroxi-3-fenilpropanamida sustituidos; inhibidores de la enzima desacetilasa; su composicion farmaceutica; utiles en el tratamiento del cancer, tumores, psoriasis, alzheimer, entre otras.
CY1113575T1 (el) Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα
AR079057A1 (es) Triaosilceramida urinaria (gb3) como marcador de enfermedad cardiaca
CL2008002545A1 (es) Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor.
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
CL2011000405A1 (es) Compuestos derivados de n-sulfonamido pirazolil policiclico; inhibidores de la liberacion y sintesis de peptidos beta-amiloides y y-secretasa; composicion farmaceutica que los comprende; y sus usos en el tratamiento de enfermedades alzheimer, parkinson, sindrome de down, entre otras.